{"database": "lobbying", "table": "lobbying_activities", "rows": [[1449013, "1abd701c-86f3-462e-a30f-1e7bdfd2b188", "Q3", "EMPIRE CONSULTING GROUP", 400703105, "PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA", 2013, "third_quarter", "PHA", "Issues relating to the Medicare Prescription Drug Act; issues relating to implementation of the Affordable Care Act;  H.R. 1588, \"Medicare Drug Savings Act of 2013\"; 340 B Drug Discount Program; HR 3204, Drug Quality & Security Act", "HOUSE OF REPRESENTATIVES", 40000, null, 0, 0, "2013-10-17T18:25:45.463000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1449013"], "units": {}, "query_ms": 388.9113150071353, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}